Cargando…

Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial

The purpose of this 21-day assessor blinded, randomized-controlled trial was to compare an open-label placebo (OLP) to treatment as usual (TAU) for cancer survivors with fatigue. This was followed by an exploratory 21-day study in which TAU participants received OLPs while OLP participants in the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoenemeyer, Teri W., Kaptchuk, Ted J., Mehta, Tapan S., Fontaine, Kevin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807541/
https://www.ncbi.nlm.nih.gov/pubmed/29426869
http://dx.doi.org/10.1038/s41598-018-20993-y

Ejemplares similares